SCHEMBL9452963

SCHEMBL9452963

Cc1nc(CP(=O)(O)O)oc1C

nearest known ligand 0.41

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 4/20 0.41
PGK2 P07205 4/20 0.41
FBP1 P09467 2/20 0.36
CCNE2 O96020 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965302 0.73
SCHEMBL5897785 0.73
SCHEMBL10626268 0.71 FDPS (0.41)
SCHEMBL10475741 0.69 MAPT (0.42) PGK1PGK2
SCHEMBL10624771 0.69 FDPS (0.43)
SCHEMBL1161722 0.69
SCHEMBL17582359 0.69
SCHEMBL10626237 0.68 FDPS (0.46)
SCHEMBL16848434 0.65 MEN1 (0.32) CCNE2CCNE1CDK2KMT2A
SCHEMBL21544541 0.62 KDM1A (0.35) CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5262540-A FOR INHIBITION OF BLOOD PLATELET AGGREGATION IN MAMMALS BRISTOL-MYERS SQUIBB COMPANY (US) 1993-11-16 US disclosed
EP-0434034-A1 Oxazole derivatives Bristol-Myers Squibb Company (US) 1991-06-26 EP disclosed